Study of FA12 peptide-modified PEGylated liposomal doxorubicin (PLD) as an effective ligand to target Muc1 in mice bearing C26 colon carcinoma: in silico, in vitro, and in vivo study

.

Source: Expert Opinion on Drug Delivery - November 24, 2022 Category: Drugs & Pharmacology Authors: Atefeh Biabangard Ahmad Asoodeh Mahmood Reza Jaafari Mohammad Mashreghi Source Type: research